Navidea Biopharmaceuticals, Inc. Welcomes Jill Bieker Stefanelli, Ph.D. to Board of Directors; Alexa

In line with the Company’s Fix, Fund, Propel approach, Jill Bieker Stefanelli, Ph.D. joins Board, adding precision medicine and product development depth in support of stated strategy to advance innovative technology to market. Separately, Alexander L. Cappello steps down.DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Bioph...

Related Keywords

Colorado ,United States ,Kansas ,Dublin ,Ireland ,American ,Jason Myers ,Jill Bieker Stefanelli ,Alexanderl Cappello ,Theodore Gerbick ,Navidea Manocept ,Invitae Archer ,Johnk Scott Jr ,Sandia National Laboratories ,Animal Sciences Industry ,Securities Exchange ,Navidea Biopharmaceuticals Inc ,Precision Medicine Companies ,Company Fix ,Company Board Of Directors ,Company Board ,Clinical Commercial Development Lead At Life Technologies ,Department Of Diagnostic Medicine Pathobiology ,Navidea Biopharmaceuticals ,Precision Medicine Leader ,Bieker Stefanelli ,Scientific Advisor ,Independent Board ,Board Member ,Chief Business Officer ,Senior Vice President ,Clinical Commercial Development Lead ,Life Technologies ,Genomics Specialist ,Roche Diagnostics ,Sandia National ,Animal Sciences ,Molecular Medicine ,Diagnostic Pathology ,Veterinary School ,Kansas State ,Vice Chair ,Securities Act ,Securities Exchange Act ,Annual Report ,